Gelatinase activity of matrix metalloproteinases in the cerebrospinal fluid of various patient populations

Research Communications in Molecular Pathology and Pharmacology

Volumn 104, Issue 1, 1999, Pages 42-52

  Valenzuela, María A ^a   Cartier, Luis ^d   Collados, Lucía ^d   Kettlun, Ana M ^d   Araya, Fernando ^d   Concha, Cecilia ^d   Flores, Lorena ^d   Wolf, Marion E ^b   Mosnaim, Aron D ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c The Chicago Medical College   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ADULT; AGED; ARTICLE; BRAIN CYSTICERCOSIS; BRAIN INFARCTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; ENZYME ACTIVITY; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; MALE; MENINGITIS; PRION DISEASE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

ENZYME ACTIVATION; GELATINASES; HUMANS; MATRIX METALLOPROTEINASES; NERVOUS SYSTEM DISEASES; PHENYLMERCURIC ACETATE; SUBSTRATE SPECIFICITY;

EID: 0032708165     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Biddison, W.E., Kubota, R., Kawanishi, T., Taub, D.D., Cruikshank, W.W., Center, D.M., Connor, E.W., Utz, U. and Jacobson, S. (1997) Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTVL-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J. Immunol. 159: 2018-2025.
2. Boyle, J.R., Dermontt, E., Crowther, M., Wills, A.D., Bell, P.R. and Thompson, M. M. (1998) Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J. Vasc. Sur. 27: 354-361.
3. Cartier, L., Cea, J.G., Vergara, C., Araya, F. and Born, P. (1997) Clinical and neuiopathological study of six patients with spastic parapesia associated with HTLV-1: An axomyelinic degeneration of the central nervous system. J. Neurophatol. Exp. Neurol. 56: 403-413.
4. Cuzner, M.L., Gveric, D., Strand, C., Loughlin, A.J., Paemen, L., Opdenakker, G. and Newcombe, J. (1996) The expression of tissue-type plasminogen activator, matrix metalloproteinases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages with lesion evolution. J. Neuropathol. Exp. Neurol. 55: 1194-1204.
5. DeVries, H.E., Kuiper, J., De Boer, A.G., VanBerkel, T.J.C. and Breimer, D.D. (1997) The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49: 143-155.
6. Friedberg, M.H., Glanzt, M.J., Klempner, M.S., Cole, B.F. and Perides, G. (1998) Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer 82: 923-930.
7. Galis, Z.S., Sukhova, G.K., Lark, M.W. and Libby, P. (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503.
8. Gijbels, K., Masure, S., Carton, H. and Opdenakker, G. (1992) Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41: 29-34.
9. Giraudon, P., Vernant, J.C., Confavreux, C., Belin, M.F. and Desgranges, C. (1998) Matrix metalloproteinas-9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesia. Neurology, 50: p. 1920.
10. Giraudon, P., Buart, S., Bernard, A. and Akaoka, H. (1999) Lymphocyte chronically infected with HTLV-1 alter the MMP/TIMP balance in glial cells through integrin and proinflammatory cytokines. JAIDS and Human Retrovirol. 20: A16
11. Kolb, S.A., Lahrtz, F., Paul, R., Leppert, D., Nadal, D., Pfister, H.W. and Fontana, A. (1998) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J. Neuroimmunol. 84: 143-150.
12. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
13. LaFleur, M., Underwood, J.L., Rappolec, DA. and Werb, Z. (1996) Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184: 2311-2326.
14. Lezin, A., Buart, S., Bourdomé, O., Perret-Liaudet, S., Smadja, D., Cesaire, R., Belin, M.F. and Giraudon, P. (1999) Overexpression of MMP-9 and TIMP-3 correlated with neopterin levels in the CSF of TSH/HAM patients and not asymptomatic carriers. JAIDS and Human Retrovirol. 20: A70.
15. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
16. Maeda, A. and Sobel, R.A. (1996) Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55: 300-309.
17. Matrisian, L.M. (1990) Metalloproteinases and their inhibitors in matrix remodeling. TIG 6: 121-125.
18. Means, G.D. and Feeney, R.E (1964) Chemical Modification of Protein. Holden-Day, California, USA.
19. Miura, T., Yamashita, M., Zaninovic, V., Cartier, L., Takehisa, J., Igarashi, T., Ido, E., Fujiyoshi, T., Sonoda, S., Tajima, K. and Hayami, M. (1997) Molecular Phylogeny of human T-cell leukemia virus type I and II of Amerindians in Colombia and Chile. J. Mol. Evol. 44(Suppl I): 576-582.
20. Parsons, S.L., Watson, S.A., Brown, P.D., Collins, H.M. and Steele, R.J.C. (1997) Matrix metalloproteinases. Br. J. Surg. 84: 160-166.
21. Perides, G., Charness, M. E., Tanner, L.M., Péter, O., Satz, N., Stecre, A.C. and Klempner, M.S. (1998) Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J. Infect. Dis. 177: 401-408.
22. Ramírez, E., Cartier, L., Ríos, M. and Fernández, J. (1999) Defective human T-cell lymphotropic virus type I (HTVI-I) provirus in 10 Chilean seronegative patients with tropical spastic paraparesis or HTVL-I-associated myelopathy J. Clin. Microbiol. 36: 1811-1813.
23. Rao, J.S., Sawaya, R., Gokaslan, Z.L., Yung, W.K.A., Goldstein, G.W. and Laterra, J. (1996) Modulation of serine proteinases and metalloproteinases during morphogenic glial-endothelial interactions. J. Neurochem. 66: 1657-1664.
24. Rosenberg, G.A. and Navratil, M. (1997) Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48: 921-926.
25. Rucklidge, G.J., Lund-Johansen, M., Milne, G., and Bjerkvig, R. (1990) Isolation and characterization of a metalloproteinase secreted by rat glioma cells in serum-free culture. Biochem. Biophys. Res. Commun. 172: 544-550.
26. Sporer, B., Paul, R., Koedel, U., Grimm, R., Wick, M., Godel, F.D. and Pfister, H.W. (1998) Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of immunodeficiency virus-infected patients. J. Infect. Dis. 178: 854-857.
27. Wehr, T., Rodriguez-Díaz, R. and Liu, C.M. (1997) Capillary electrophoresis of proteins. In. Advances in Chromatography 37: 238-361. (E. P.R. Brown and E. Grushka, ed).
28. Woessner, J.F., (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB, J. 5: 2145-2154.